The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps

• Status: Enrolling by invitation
• Trial end date: 2020-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The study hypothesis is whether digestion enzyme(Combizym) and intestinal flora drugs(Bifidobacteria) can decease recurrence rate of colon polyps

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: RenJi Hospital
• Treatments: Pancreatin; Pancrelipase

Criteria

Inclusion Criteria:

-Patients who have cutted colon polyps in one month, and the diagnosis were proved by pathological analysis

Exclusion Criteria:

• have organic or other functional disease

• pregnant or breast-feeding